Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00494169 · ClinicalTrials.gov registry record
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 4,042
- Enrollment target
NCT00494169: Completed study, sponsored by Massachusetts General Hospital.
NCT00494169 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 4,042 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00494169 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 4,042 participants
- Enrollment target
Study Summary
The aims of this study are: 1) to identify genes that play a role in human pubertal development and reproduction, 2) to characterize the phenotypic spectrum of patients with these gene defects, and 3) to discern the mode of inheritance for disorders caused by these gene defects. We are specifically interested in genes that cause Kallmann syndrome, idiopathic hypogonadotropic hypogonadism (IHH), precocious (early) puberty, and delayed puberty. Individuals do not have to travel to Boston to participate in this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,042 participants |
| Start Date | 1999-01 |
| Est. Completion | 2022-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00494169
The ClinicalTrials.gov registry entry for NCT00494169 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,042 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00494169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00494169 about?
NCT00494169 is a clinical study titled "Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders". The aims of this study are: 1) to identify genes that play a role in human pubertal development and reproduction, 2) to characterize the phenotypic spectrum of patients with these gene defects, and 3) to discern the mode of inheritance for disorders caused by these gene defects. We are specifically ...
What is the current status of trial NCT00494169?
This trial is currently completed. The enrollment target is 4,042 participants. The study started on 1999-01. Estimated completion is 2022-02.
Who is sponsoring clinical trial NCT00494169?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.